Pompe disease is less prevalent than expected in Spain, at around 3.1 cases per million inhabitants, according to a…
Andrea Lobo, PhD
Andrea Lobo holds a PhD in cell biology/neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She has authored multiple research papers in peer-reviewed journals.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo, PhD
Mitochondria dysfunction is linked to hypertrophic cardiomyopathy — when the heart becomes enlarged and cannot pump blood efficiently — in…
The use of a multidisciplinary treatment approach was described in a recent case report of a boy in the U.S.
Heart defects detected with cardiac MRI (CMR) may help diagnose classic infantile-onset Pompe disease in early childhood, a case…
Blood levels of neurofilament light chain (NfL) — a marker of nerve cell damage — are increased from infancy to…
Enzyme replacement therapy (ERT) for Pompe disease can be safely implemented at home, according to a study in the…